← Leaderboards
Tiffany Anne Reese
Ut Southwestern Medical Center
$8,068,069
Attributed
$8,068,069
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.1M · FY2018–25$2.5M$1.9M$1.3M$625K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,068,069 · 3
By mechanism
U19$4,396,977 · 1
R01$3,220,092 · 1
R21$451,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Virus”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$206,525,404
- Leonard Freedman · Leidos Biomedical Research, Inc.$79,828,969
- Ted Ross · University Of Georgia$71,962,304
- Beth Baseler · Leidos Biomedical Research, Inc.$67,833,289
- Tony Moody · Duke University$66,767,417
- Matthew Johnson · Duke University$61,899,930
Research focus
VirusParasitesParasitic InfectionImmune SystemGammaherpesvirusIntestinesHelminth InfectionInfectionHelminthsCo-InfectionImmune ResponseReportingInsightMacrophageInterleukin-4Signal TransductionHerpesviridae InfectionsHerpesviridaeMouse ModelGrantChronic InfectionCytokinePhenotypeReactivation From Latency
Grant awards (13)
Defining Mechanisms for Parasite-Driven Effects on Gamma-Herpesvirus Latency$470,420
R01 · FY2025 · AI · contact PI
Programming Offspring Immunity By In Utero Exposure to Maternal Helminth Infection$451,000
R21 · FY2025 · AI · contact PI
Defining Mechanisms for Parasite-Driven Effects on Gamma-Herpesvirus Latency$484,968
R01 · FY2024 · AI · contact PI
Defining Mechanisms for Parasite-Driven Effects on Gamma-Herpesvirus Latency$78,007
R01 · FY2024 · AI · contact PI
RP1: Targeting Beclin 1 complexes for broad-spectrum anti-infective therapeutics$1,334,248
U19 · FY2023 · AI · contact PI
Defining Mechanisms for Parasite-Driven Effects on Gamma-Herpesvirus Latency$484,968
R01 · FY2023 · AI · contact PI
RP1: Targeting Beclin 1 complexes for broad-spectrum anti-infective therapeutics$1,398,824
U19 · FY2022 · AI · contact PI
RP1: Targeting Beclin 1 complexes for broad-spectrum anti-infective therapeutics$1,663,905
U19 · FY2021 · AI · contact PI
Defining Mechanisms for Parasite-Driven Effects on Gamma-Herpesvirus Latency$405,000
R01 · FY2021 · AI · contact PI
Defining Mechanisms for Parasite-Driven Effects on Gamma-Herpesvirus Latency$405,000
R01 · FY2020 · AI · contact PI
Defining Mechanisms for Parasite-Driven Effects on Gamma-Herpesvirus Latency$81,729
R01 · FY2020 · AI · contact PI
Defining Mechanisms for Parasite-Driven Effects on Gamma-Herpesvirus Latency$405,000
R01 · FY2019 · AI · contact PI
Defining Mechanisms for Parasite-Driven Effects on Gamma-Herpesvirus Latency$405,000
R01 · FY2018 · AI · contact PI